These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16266820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
    Senft A, Hoekstra OS, Witte BI, Leemans CR, de Bree R.
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY.
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
    Kitagawa Y, Nishizawa S, Sano K, Sadato N, Maruta Y, Ogasawara T, Nakamura M, Yonekura Y.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G, Brouwer J, de Bree R, Pruim J, van der Laan BF, Vaalburg W, Hoekstra OS, Comans EF, Vissink A, Leemans CR, Roodenburg JL.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [Abstract] [Full Text] [Related]

  • 15. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY.
    Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
    Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA.
    Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
    [Abstract] [Full Text] [Related]

  • 20. The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
    Senft A, Yildirim G, Hoekstra OS, Castelijns JA, René Leemans C, de Bree R.
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1113-1120. PubMed ID: 27804082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.